Recent Advances in Nanotechnology for Dendritic Cell-Based Immunotherapy
Dendritic cells (DCs) are the most important antigen-presenting cells that determine cancer immune responses by regulating immune activation and tolerance, especially in the initiation stage of specific responses. Manipulation of DCs to enhance specific antitumor immune response is considered to be...
Main Authors: | Chen Qian, Li-Jun Yang, Hong Cui |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.00960/full |
Similar Items
-
Recent Advances in Experimental Dendritic Cell Vaccines for Cancer
by: Ivan Y. Filin, et al.
Published: (2021-09-01) -
Current state and prospects of using dendritic cell vaccination for cancer immunotherapy
by: I.Yu. Filin, et al.
Published: (2022-09-01) -
Immunosuppression Reversal Nanovaccines Substituting Dendritic Cells for Personalized Cancer Immunotherapy
by: Hu Chen, et al.
Published: (2022-06-01) -
Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen
by: Stefanie K. Wculek, et al.
Published: (2019-04-01) -
Mannose‐Modified Multi‐Walled Carbon Nanotubes as a Delivery Nanovector Optimizing the Antigen Presentation of Dendritic Cells
by: Zhipeng Dong, et al.
Published: (2019-07-01)